SURGLASSES Secures $6.5M Investment to Advance AR Surgical Navigation - Introducing Caduceus S

Spinal Tech

In a significant milestone, SURGLASSES has successfully secured $6.5 million in Pre-A funding, led by Taiwania Capital, and supported by renowned venture capital firms, including Integrated Capital, 500 STARTUPS V, L.P. (U.S.), Wisdom Capital Limited Partnership, and Sustainable Impact Capital (SIC). This achievement surpasses the initial $5 million target, highlighting robust investor confidence in SURGLASSES.

The newly infused funds are earmarked to expedite the development of Caduceus S, an FDA-cleared AR navigation system meticulously crafted for intricate spinal surgeries. A noteworthy feature is its tailored efficiency for surgery centers, eliminating the need for pre-operative or intra-operative CT scans. Caduceus S seamlessly connects to a single C-arm within the facility, making it exceptionally easy to adopt for spine surgeries.

Functionally, Caduceus S projects real-time 3D spinal anatomy onto a Head-Mounted Display (HMD), providing surgeons with precise guidance during procedures without the requirement for external monitors. This not only enhances surgical accuracy but also streamlines operations, catering specifically to the unique needs and workflow of surgery centers.

Miron Wang, CEO of SURGLASSES, emphasized, "Our AR spinal surgery navigation system is recognized as a global frontrunner". With a newly patented capability for precise navigation using just one C-arm, we prioritize patient safety by minimizing radiation exposure. They are strategically positioned for substantial growth in the U.S. market."

SURGLASSES extends a warm invitation to professionals in the MedTech field to contribute to the development of this cutting-edge technology tailored for surgery centers. The objective is to establish Caduceus S as a benchmark in global medical communities, solidifying SURGLASSES as a pioneer in AR surgical navigation systems with a sharp focus on optimizing efficiency and addressing the specific needs of surgery centers.

This strategic funding infusion aligns with SURGLASSES's commitment to advancing medical technology, enhancing surgical precision, and contributing to the evolution of AR navigation systems. As the company propels forward, the synergy between groundbreaking technology and the surgical ecosystem is poised to reshape the landscape of spinal surgeries, setting a new standard for innovation, safety, and efficiency.

In addition, the heightened efficacy, and specialized features inherent in Caduceus S make it exceptionally fitting for implementation in surgery centers. This opens up an avenue for expanded usage within these distinct medical environments, offering a substantial opportunity for enhanced operational efficiency.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Webinars

Featured Whitepapers